Product Images Tobramycin
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 21 images provide visual information about the product associated with Tobramycin NDC 47335-171 by Sun Pharmaceutical Industries, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This appears to be a figure description showing two studies comparing the effects of a drug (tobramycin) and a placebo on log CFUs. The figure shows the average change in log CFUs over time (measured in weeks) for both the drug and placebo groups in each study. However, without visual context of the figure, it is difficult to provide a complete and accurate description.*
The text describes a diagram labeled "Figure A" that includes an air compressor, nebulizer cup, inspiratory mouthpiece, clean paper or cloth towels, and tubing. It seems to be instructions or a guide for using these items, but without more context it is unclear what the purpose or application is.*
The text seems to show an image caption "Figure E" and a label for a nebulizer, including a nebulizer cup. No further information is available.*
Tobramycin Inhalation Solution, USP is a prescription medicine used for inhalation by Nebulizer. Each 5 mL ampule contains one 300 mg dose of Tobramycin USP and 11.25 mg Sodium Chloride in Water for injection. The medicine is stored in a refrigerator and contains no preservatives. The package contains 56 single-dose 5 mL ampules that provide a 28-day supply. Dosage and Administration details are provided in the package insert. For more information, you can visit the website sunpharma.com.*
Figure 1 shows the relative change from baseline in FEV1% predicted for four different groups - Study 1 Tobramycin (n=109), Study 2 Tobramycin (n=149), Study 1 Placebo (n=114) and Study 2 Placebo (n=148). The horizontal axis represents time and the vertical axis represents the percentage change from baseline in FEV1% predicted. The study periods are 24 weeks in duration with baseline measurements taken at the beginning of the period.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.